Marie-Julie Guichard joined us on last 29 October 2018. She will be in charge of translational and regulatory studies.
Marie-Julie is a PhD from the University of Louvain in Belgium where she worked on the preclinical development of a drug treatment for cystic fibrosis patients. During her training period, she also benefited from a US research experience in a biotech company in Cambridge, MA.
Op2Lysis has been selected to join Neighborhood, a life science innovation center developed by Voisin Consulting Life Sciences that supports health tech startups in providing strategic and development regulatory coaching to favor growth. Marie-Julie will be working at Neighborhood office space and will benefit from a regulatory mentoring adapted to her new responsibilities
Last October 29th was also the World Stroke Day, which is a very good sign. We wish Marie-Julie every success in her new assignment, which is a key role for Op2Lysis preclinical development progress.